Showing results (301-310 of 486) with videos related to
Sort By:
Pageof 49
Oncoimmunology|April 28, 2022
A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patientsJulie Le Naour, Zsofia Sztupinszki, Vincent Carbonnier, et al.Methods in Cell Biology|September 5, 2022
Cytofluorometric assessment of cell cycle progression in irradiated cellsCarlos Jiménez-Cortegana, Vanessa Klapp, Norma Bloy, et al.Oncoimmunology|February 6, 2014
Trial Watch: Peptide vaccines in cancer therapyFernando Aranda, Erika Vacchelli, Alexander Eggermont, et al.Methods in Cell Biology|October 11, 2024
Cytofluorometric assessment of calreticulin exposure on CD38+ plasma cells from the human bone marrowManuel Beltrán-Visiedo, Alfonso Serrano-Del Valle, Nelia Jiménez-Aldúan, et al.Biochemical Pharmacology|July 12, 2008
Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparisonSimone Boehrer, Lionel Adès, Lorenzo Galluzzi, et al.Oncoimmunology|May 7, 2014
Trial Watch: Chemotherapy with immunogenic cell death inducersErika Vacchelli, Fernando Aranda, Alexander Eggermont, et al.Methods in Molecular Biology (Clifton, N.J.)|June 5, 2013
Fluorescent biosensors for the detection of HMGB1 releaseIsabelle Martins, Oliver Kepp, Laurie Menger, et al.Cell Cycle (Georgetown, Tex.)|August 3, 2013
Antiapoptotic activity of argon and xenonSabrina Spaggiari, Oliver Kepp, Santiago Rello-Varona, et al.Oncoimmunology|June 5, 2013
Trial watch: DNA vaccines for cancer therapyLaura Senovilla, Erika Vacchelli, Pauline Garcia, et al.Oncoimmunology|December 7, 2017
Trial watch: DNA-based vaccines for oncological indicationsStefano Pierini, Renzo Perales-Linares, Mireia Uribe-Herranz, et al.Pageof 49